96 related articles for article (PubMed ID: 28116719)
1. In Vitro and In Vivo Approaches to Assess Rho Kinase Activity.
Sauzeau V; Loirand G
Methods Mol Biol; 2017; 1527():213-218. PubMed ID: 28116719
[TBL] [Abstract][Full Text] [Related]
2. The Lbc Rho guanine nucleotide exchange factor α-catulin axis functions in serotonin-induced vascular smooth muscle cell mitogenesis and RhoA/ROCK activation.
Bear MD; Li M; Liu Y; Giel-Moloney MA; Fanburg BL; Toksoz D
J Biol Chem; 2010 Oct; 285(43):32919-32926. PubMed ID: 20696764
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of Rhoa/Rho kinase pathway by translationally controlled tumor protein in vascular smooth muscle cells.
Maeng J; Sheverdin V; Shin H; Ha I; Bae SS; Yang-Yen HF; Lee K
Int J Mol Sci; 2014 Jun; 15(6):10365-76. PubMed ID: 24918292
[TBL] [Abstract][Full Text] [Related]
4. Myosin phosphatase-Rho interacting protein. A new member of the myosin phosphatase complex that directly binds RhoA.
Surks HK; Richards CT; Mendelsohn ME
J Biol Chem; 2003 Dec; 278(51):51484-93. PubMed ID: 14506264
[TBL] [Abstract][Full Text] [Related]
5. Activation of cold-sensing transient receptor potential melastatin subtype 8 antagonizes vasoconstriction and hypertension through attenuating RhoA/Rho kinase pathway.
Sun J; Yang T; Wang P; Ma S; Zhu Z; Pu Y; Li L; Zhao Y; Xiong S; Liu D; Zhu Z
Hypertension; 2014 Jun; 63(6):1354-63. PubMed ID: 24637663
[TBL] [Abstract][Full Text] [Related]
6. Acute glucose influx-induced mitochondrial hyperpolarization inactivates myosin phosphatase as a novel mechanism of vascular smooth muscle contraction.
Xu J; Yang H; Yang L; Wang Z; Qin X; Zhou J; Dong L; Li J; Zhu M; Zhang X; Gao F
Cell Death Dis; 2021 Feb; 12(2):176. PubMed ID: 33579894
[TBL] [Abstract][Full Text] [Related]
7. Molecular aspects of arterial smooth muscle contraction: focus on Rho.
Hilgers RH; Webb RC
Exp Biol Med (Maywood); 2005 Dec; 230(11):829-35. PubMed ID: 16339747
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice.
Cao X; Luo T; Luo X; Tang Z
Hypertens Res; 2014 Sep; 37(9):803-10. PubMed ID: 24965170
[TBL] [Abstract][Full Text] [Related]
9. Rho kinase and hypertension.
Wirth A
Biochim Biophys Acta; 2010 Dec; 1802(12):1276-84. PubMed ID: 20460153
[TBL] [Abstract][Full Text] [Related]
10. 2-Methoxyestradiol blocks the RhoA/ROCK1 pathway in human aortic smooth muscle cells.
Rigassi L; Barchiesi Bozzolo F; Lucchinetti E; Zaugg M; Fingerle J; Rosselli M; Imthurn B; Jackson EK; Dubey RK
Am J Physiol Endocrinol Metab; 2015 Dec; 309(12):E995-1007. PubMed ID: 26487003
[TBL] [Abstract][Full Text] [Related]
11. A role for Rho-kinase in Ca-independent contractions induced by phorbol-12,13-dibutyrate.
Baek I; Jeon SB; Kim J; Seok YM; Song MJ; Chae SC; Jun JE; Park WH; Kim IK
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):256-61. PubMed ID: 18986333
[TBL] [Abstract][Full Text] [Related]
12. Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation.
Ying Z; Giachini FR; Tostes RC; Webb RC
Cardiovasc Res; 2009 Jul; 83(1):155-62. PubMed ID: 19276129
[TBL] [Abstract][Full Text] [Related]
13. Elevated RhoA/Rho-kinase activity in the aged rat penis: mechanism for age-associated erectile dysfunction.
Jin L; Liu T; Lagoda GA; Champion HC; Bivalacqua TJ; Burnett AL
FASEB J; 2006 Mar; 20(3):536-8. PubMed ID: 16396994
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin inhibits myocardin expression in vascular smooth muscle cells.
Li J; Jiang J; Yin H; Wang L; Tian R; Li H; Wang Z; Li D; Wang Y; Gui Y; Walsh MP; Zheng XL
Hypertension; 2012 Jul; 60(1):145-53. PubMed ID: 22615115
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells.
Xie Z; Su W; Guo Z; Pang H; Post SR; Gong MC
Cardiovasc Res; 2006 Feb; 69(2):491-501. PubMed ID: 16336954
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of SAR407899, a novel rho-kinase inhibitor.
Löhn M; Plettenburg O; Ivashchenko Y; Kannt A; Hofmeister A; Kadereit D; Schaefer M; Linz W; Kohlmann M; Herbert JM; Janiak P; O'Connor SE; Ruetten H
Hypertension; 2009 Sep; 54(3):676-83. PubMed ID: 19597037
[TBL] [Abstract][Full Text] [Related]
17. Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2+-induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells.
Yoshioka K; Sugimoto N; Takuwa N; Takuwa Y
Mol Pharmacol; 2007 Mar; 71(3):912-20. PubMed ID: 17179444
[TBL] [Abstract][Full Text] [Related]
18. Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction.
Sakurada S; Takuwa N; Sugimoto N; Wang Y; Seto M; Sasaki Y; Takuwa Y
Circ Res; 2003 Sep; 93(6):548-56. PubMed ID: 12919947
[TBL] [Abstract][Full Text] [Related]
19. RhoA/Rho-kinase, vascular changes, and hypertension.
Chitaley K; Weber D; Webb RC
Curr Hypertens Rep; 2001 Apr; 3(2):139-44. PubMed ID: 11276396
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Ca2+-dependent activation of phosphoinositide 3-kinase class IIα isoform-Rho axis in blood vessels of spontaneously hypertensive rats.
Seok YM; Azam MA; Okamoto Y; Sato A; Yoshioka K; Maeda M; Kim I; Takuwa Y
Hypertension; 2010 Nov; 56(5):934-41. PubMed ID: 20921425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
